Clinical Trials Browser

Phase 3 × Completed × Non-small Cell Lung Cancer Metastatic × Clear all

NCT04923945 2025-03-07

Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Patients

Phase 3 Completed

Non-small Cell Lung Cancer Metastatic

NCT01966003 2017-10-19

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Phase 3 Completed

642 enrolled 17 charts

Non-small Cell Lung Cancer Metastatic